Hospital Universitari De Girona Doctor Josep Trueta

At Hospital Universitari De Girona Doctor Josep Trueta, research in cardiovascular diseases focuses on stroke, myocardial protection, and heart failure prevention. These trials are testing new treatments and strategies to reduce damage after acute events, improve recovery, and lower the risk of future cardiovascular complications.

• Acute ischemic stroke and prevention of recurrent stroke
• Tranexamic acid and other therapies for intracerebral hemorrhage
• Cardiovascular risk reduction in obesity and related conditions
• Therapies for genetic dilated cardiomyopathy and ventricular function preservation

The site is contributing to studies that aim to improve emergency care, support long-term prevention, and evaluate whether newer approaches can make cardiovascular treatment more effective and safer.

Clinical research in neoplasms covers several major cancers, including prostate cancer, breast cancer, endometrial cancer, bladder cancer, renal cancer, and lung cancer. The trials are mainly designed to test new cancer therapies, compare treatment combinations, and improve outcomes after surgery or during advanced disease.

• Advanced and early-stage breast cancer
• Metastatic and castration-resistant prostate cancer
• Endometrial, bladder, and renal cancers
• Non-small cell lung cancer and other solid tumors

This oncology portfolio reflects a strong focus on evaluating treatment effectiveness, extending survival, and helping define better options for patients with hard-to-treat cancers.

The site also supports studies in nervous system diseases, especially multiple sclerosis and acute brain injury. Research here is centered on improving stroke care, testing therapies that may protect brain tissue, and assessing longer-term safety and benefit in chronic neurological disorders.

• Acute stroke treatment and clot-related brain injury
• Prevention of ischemic stroke after transient ischemic attack
• Long-term therapy for relapsing and progressive multiple sclerosis
• Evaluation of emergency and hospital-based neuroprotective approaches

These trials are aimed at better recovery, fewer complications, and more reliable treatment options for patients with urgent and chronic neurological conditions.

In digestive system diseases, the research includes Crohn's disease and ulcerative colitis. The studies are focused on improving symptom control, supporting remission, and finding more effective maintenance treatments for people living with inflammatory bowel disease.

• Clinical remission in ulcerative colitis
• Maintenance treatment for Crohn's disease
• Long-term safety and effectiveness of inflammatory bowel disease therapies

This work helps evaluate whether newer medicines can provide better disease control and a more durable response over time.

The site’s activity in respiratory tract diseases and virus diseases includes studies in pneumonia, bronchiectasis, SARS-CoV-2 infection, and influenza. Research here is aimed at testing treatments for serious lung infections and assessing vaccine safety, tolerability, and immune response in different age groups.

• Severe community-acquired pneumonia and other serious respiratory infections
• Chronic Pseudomonas aeruginosa infection in bronchiectasis
• COVID-19 and influenza vaccine studies
• Therapies targeting infectious burden and immune protection

These trials support both treatment development and prevention, with an emphasis on reducing infection-related complications and strengthening public health protection.

Research in nutritional and metabolic diseases and reproductive and urinary physiological phenomena includes studies on obesity and contraceptive efficacy. The goal is to evaluate whether new approaches can improve cardiovascular safety in excess weight and offer reliable options for pregnancy prevention.

• Cardiovascular safety in people with overweight or obesity
• Evaluation of contraceptive effectiveness and tolerability

This area combines prevention-focused research with practical questions relevant to everyday health and long-term wellbeing.